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Phosphorylation is a posttranslational modiﬁcation that is
widely used by eukaryotic (but also by prokaryotic) cells to regu-
late, activate or modify various cellular processes. Therefore it is
not surprising that phosphorylation also regulates many critical
steps within the circadian clock mechanism. Phosphorylation can
change the activity of a protein (e.g., of a kinase), its binding prop-
erties to other proteins, its subcellular localisation (e.g., of a tran-
scription factor, for a review see [1]), its stability and thus the
function of a protein in any given system. In the circadian clock
of cyanobacteria, for example, phosphorylation plays an extraordi-
nary role – the clock works even in vitro just by cycles of phosphor-
ylation and dephosphorylation of the KaiC protein in the presence
of KaiA, KaiB and ATP [2,3] (for a review see [4]). In eukaryotic
clocks phosphorylation is also very important although other reg-
ulatory mechanisms (e.g., rhythmic transcription) and additional
posttranscriptional modiﬁcations are necessary to generate and
ﬁne-tune circadian oscillations.
In all eukaryotes the fundamental basis of circadian rhythm
generation is similar, yet the players are different. At the core of
the clockwork is an autoregulatory negative feedback loop. Positive
elements, transcription factors, enhance the expression of clock
genes whose gene products then act negatively on their own tran-
scription by inhibiting the positive elements. The most important
components of the core of the circadian feedback loop in differentchemical Societies. Published by E
er).model organisms are shown in Table 1. Additional complexity
arises from supplemental loops and components linked to this cen-
tral feedback loop. In mammals for example, REV-ERBa (NR1D1,
nuclear receptor subfamily 1, group D, member 1) acts in a positive
loop as an inhibitor of Bmal1 expression. Despite this complexity,
the principle mechanism of circadian rhythm generation is a sim-
ple negative feedback loop. It is easily conceivable that an oscilla-
tion on transcript level of clock genes and clock output genes can
be achieved by a negative feedback. However, one major issue
has to be tackled by the cell: on top of creating an oscillation, the
period of the oscillation has to be approximately 24 h to generate
a circadian rhythm. To achieve this goal there has to be an enor-
mous delay within the negative feedback loop, as biochemical pro-
cesses usually occur rather in the range of seconds to minutes than
in the range of hours [5].
To generate this delay posttranslational modiﬁcations play a
crucial role and phosphorylation is so far the most widely identi-
ﬁed modiﬁcation in the circadian clock mechanism. Many clock
components are rhythmically phosphorylated including CLOCK
[6], CRYs [7], BMAL1 [8] and PERs [9]. The phosphorylation pattern
of mouse PER2, for example, has been studied extensively. Mouse
PER2 has 247 serine or threonine residues that can potentially be
phosphorylated. Of these, 21 were found to be phosphorylated by
endogenous kinases in cultivated cells. This pattern of phosphory-
lation is bound to represent only a mean state, as the analysis was
not performed in oscillating cells [10]. The rhythmic phosphoryla-
tion of a protein is achieved by the regulated action of kinases and
phosphatases that counterbalance their activity with different
activities at different time windows. In the following, we reviewlsevier B.V. All rights reserved.
Table 1
Central components of the core negative feedback loop of eukaryotic circadian clocks.
Organism Negative
factor(s)
Positive factors
Neurospora FREQUENCY
(FRQ)
WHITE COLLAR COMPLEX (WCC) consisting
of WHITE COLLAR 1 (WC-1) and WHITE
COLLAR 2 (WC-2)
Drosophila PERIOD (PER) CLOCK (CLK)
TIMELESS (TIM) CYCLE (CYC)
Mammals PERIOD (PER1-3) Circadian locomotor output cycle Kaput
(CLOCK)
CRYPTOCHROME
(CRY 1 and 2)
Brain and muscle aryl hydrocarbon receptor
nuclear translocator (ARNT)-Like 1 (BMAL1)
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2. Protein kinases
2.1. Casein kinase I (CKI)
In the bread mould (Neurospora crassa) many kinases play a
dual role by acting on both the negative and positive elements of
the circadian system. CK1-a, the Neurospora homologue to mam-
malian CKI, phosphorylates and destabilizes the transcriptional
repressor FRQ. Furthermore it is required for FRQ-dependent phos-
phorylation and thereby inhibition of the activity of WCC, the Neu-
rospora transcriptional activator [11,12].
In both the Drosophila and the mammalian clock, the rhythmic
phosphorylation of PER proteins is an important feature and is
therefore tightly regulated. In mammals, the rhythmic abundance
of PER2 is crucial for normal oscillations, whereas the oscillation
of Per2 transcript levels is not necessary. A constant expression
of Per2 can lead to a rhythmic abundance of PER2 if PER2 is rhyth-
mically phosphorylated and if the level of PER2 is in a physiological
range [13]. Overexpression of PER2, however, disrupts circadian
oscillations in ﬁbroblasts and liver [14]. CKI is presumably the
most important kinase responsible for PER protein phosphoryla-
tion, and its role was extensively studied in the circadian ﬁeld. In
mammals, there are seven distinct genes encoding CKI isoforms
(a, b, c1, c2, c3, d and e), of which d and e have been described
to be involved in regulating the circadian clock [15]. In the
Drosophila clock, the substrates of DOUBLETIME (DBT, the ortho-
logue to vertebrate CKIe) are PER and CLK. DBT is responsible for
phosphorylating the PER protein and thereby regulating its abun-
dance in pacemaker neurons. Phosphorylation by DBT targets
PER for recognition by the F-box protein SLIMB and subsequent
ubiquitination and proteasomal degradation [16–18]. Depending
on the speciﬁc site of PER that is phosphorylated by DBT, the result
is either an unstable but highly active repressor or a stable PER
with little repressor activity [19]. Furthermore, it was found that
DBT hyperphosphorylates and destabilises CLK in Drosophila,
which is counteracted by phosphatase PP2A [20]. Interestingly, a
novel non-catalytic role for DBT in the phosphorylation of CLK
(possibly by recruiting other kinases) is proposed [21]. The overall
effect of lowering the DBT kinase activity on circadian period is
equivocal. There are mutant alleles that either lengthen or shorten
the circadian period although the kinase activity is reduced in both
cases [22].
In the mammalian clock, the substrates of CKIe/d are PER1
[23,24], PER2 [25,26], BMAL1 and CRY proteins [27]. A natural
CKI mutation, the tau mutation, was described in golden hamster
already in 1988 [28]. When carried homozygously it shortens the
period of free-running locomotor activity rhythms dramatically
but also when carried heterozygously it produces an about 2-hourshorter period. More than ten years later the tau mutation was
allocated to the CKIe gene by positional cloning. A single point
mutation causing an arginine to cysteine exchange at a highly con-
served position results in CKIe-tau. In vitro, the mutant tau-kinase
has a reduced velocity of substrate phosphorylation, whereas the
binding afﬁnity to its substrates PER1, PER2 and others is only
slightly altered [29]. In a mouse model of tau, CKIe-tau acts by pro-
moting the degradation of PER proteins [30]. Therefore, tau has
been suggested to be a gain-of-function rather than a loss-of-func-
tion mutation. How precisely this correlates with the reduced
phosphorylation velocity in vitro is still unclear.
A second naturally occurring mutation of CKI was identiﬁed in
humans suffering from familial advanced sleep phase syndrome
(FASPS) [31–33]. Affected individuals exhibit a phase in sleep-wake
cycles, body temperature rhythms, etc. that is advanced by about
4 h compared to the average population. In one family FASPS cor-
relates with a threonine to alanine substitution in CKId leading to
a reduced kinase activity in vitro [33]. Interestingly, a second fam-
ily exhibiting the same syndrome has a point mutation in the Per2
coding sequence, which leads to a serine to glycine exchange in the
CKIe/d binding site of PER2 [32]. In a molecular study, it was shown
that FASPS-PER2 is more sensitive to CKIe-triggered degradation
and is destabilised compared to wildtype PER2. A model to explain
this behaviour proposes two groups of phosphorylation sites in the
PER2 protein, one group of phosphorylations stabilises, while the
other destabilises PER2. Depending on the speciﬁc residues that
are phosphorylated, the stability of PER2 is modiﬁed in one or an-
other direction. Phosphorylation at the FASPS-site (Ser 659) by a
yet unknown kinase and a conserved downstream phosphoaccep-
tor cluster by CKIe or d leads to nuclear retention and stabilisation
of PER2 [10]. If these phosphorylation events are perturbed – as it
is the case in the two forms of FASPS – nuclear repression is re-
leased earlier resulting in a shorter circadian cycle and thus an ear-
lier phase.
CKIe-mediated phosphorylation can also destabilise PER pro-
teins in mammals. CKIe-phosphorylation of PER1 and PER2 targets
them for proteasomal degradation. This is achieved by phosphory-
lation of speciﬁc sites (phosphodegrons) recognised by the F-box
proteins b-TrCP1/2 that are part of an E3 ubiquitin ligase complex
[34–36].
The activity of CKIe/d is of crucial importance for the generation
of normal circadian periods. This has been shown in a cell-based
screen with 1260 pharmacologically active compounds for period
modulating activities. Most compounds that markedly lengthened
the circadian period were inhibitors of CKIe and d [37]. Assessing
the speciﬁc contribution of the isoforms of CKI – e and d – for cir-
cadian rhythm generation turned out to be difﬁcult, since (i) CKId
loss-of-function mutations are embryonic lethal in mice and (ii)
compensation effects between e and d had to be dealt with. One
study looked at molecular rhythms in CKId-deﬁcient mouse
embryonic ﬁbroblasts (MEFs), which show a lengthened period.
When a dominant negative, catalytically inactive form of CKIe is
overexpressed in these CKId-deﬁcient MEFs (hence both CKIe and
d were inactive) circadian rhythms were essentially eliminated
[38]. A second study generated mice with liver speciﬁc deletions
in the genes coding for both CKIe and d. In this in vivo study, a ma-
jor role for CKId emerged: disruption of CKId leads to a lengthened
period, whereas disruption of CKIe did not change the circadian
period in liver explants [39]. Additional evidence supporting the
putatively stronger role of CKId for circadian rhythmicity comes
from a pharmacological study with a speciﬁc inhibitor to CKIe that
did not cause a circadian phenotype in contrast to unspeciﬁc inhib-
itors to both CKI isoforms [40]. Together, these studies seem to
indicate that both CKI isoforms – e and d – contribute to circadian
rhythm generation with CKId being able to fully compensate for
the loss of CKIe and CKIe only partly compensating for the deletion
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isoform is important for the clock under physiological conditions
or whether it only acts in the absence of functional CKId. In a recent
publication yet another CKI isoform, CKIa, emerges as a member of
the mammalian circadian clock. In a screen of ca 120 000 small
chemical components for their action on circadian clock period,
one component was discovered that bound and inhibited CKId,
CKIa and ERK2 (MAPK1 – mitogen activated protein kinase 1)
and lengthened the circadian period [41]. Although knockdown
of each of the kinases had an effect on circadian period, the simul-
taneous knockdown drastically lengthens the period pointing to-
wards a multi-kinase-network involved in maintaining circadian
oscillations.
2.2. Casein kinase 2 (CK2)
In Neurospora, CKII exhibits a dual function, similar to CK1-a. On
the one hand it phosphorylates and destabilizes FRQ and on the
other it inhibits WCC activity by FRQ-dependent WCC phosphory-
lation [11,42].
In Drosophila the role of CK2 in the circadian system has been
well established for several years before a role in the mamma-
lian system emerged recently. One reason may be the plethora
of cellular functions into which mammalian CK2 is involved
[43] and the resulting difﬁculties in dissecting the different pro-
cesses. CK2 is ubiquitously expressed. The CK2 holoenzyme con-
sists of four subunits, two catalytic a subunits (a and/or a0 in
mammals) and two regulatory b subunits responsible for sub-
strate recognition.
In Drosophila two mutant alleles of CK2 with an effect on circa-
dian rhythmicity have been reported: Timekeeper, Tik, is a domi-
nant negative mutation in the catalytic a subunit and Andante,
And, causes impaired dimerisation of the regulatory b subunits. Re-
duced CK2 activity leads to delayed nuclear entry of PER and TIM
and long-period phenotypes. In vitro, CK2 can phosphorylate both
TIM and PER [44–47]. Mutation of putative CK2 phosphorylation
sites in PER phenocopies the Timekeeper mutation in the catalytic
subunit of CK2 [48].
In mammals, inhibition of CK2 activity or downregulation of its
expression leads to lengthened circadian periods in cell culture
models. Here, two different roles of CK2 have been described: with
either PER2 or BMAL1 as CK2 substrates. Two partly contradictory
publications show that PER2 is a CK2 substrate in vitro. While one
publication proposes a PER2 stabilising effect upon CK2-mediated
phosphorylation [49], the other one proposes a PER2 destabilising
effect when CK2 cooperates with CKIe [50]. Both studies map the
CK2 phosphorylation sites to different serine residues in the N-ter-
minal part of the PER2 protein. Apart from PER2, BMAL1 was found
to be a CK2 substrate. CK2 phosphorylates BMAL1 on serine 90 and
promotes its nuclear entry. Mutation of BMAL1 on serine 90 leads
to a loss of circadian rhythmicity [8].
2.3. Glykogen synthase kinase 3 (GSK3)
The kinase GSK3 regulates the circadian clock in many organ-
isms. Additionally it is involved in several cellular pathways and
has been linked to a large number of diseases including Alzheimer´s
disease, diabetes, cancer and psychiatric disorders such as schizo-
phrenia and bipolar mood disorder [51,52]. Lithium, a known GSK3
inhibitor is used to treat bipolar disorder and patients suffering
from this disease also show circadian and sleep disturbances
[53]. In line with these observations, the GSK3 homologue SHAGGY
(SGG) inﬂuences circadian rhythms in Drosophila. When overex-
pressed in pacemaker neurons, the period is shortened by approx-
imately 3 h. Downregulation of sgg results in a lengthened
circadian period. SGG was shown to phosphorylate TIM in vitro.Shaggy overexpression leads to increased phosphorylation of TIM
in vivo and an advanced entry of the PER/TIM complex into the nu-
cleus of circadian pacemaker neurons [54]. In addition it was
shown recently that SGG also directly phosphorylates PER if a crit-
ical Ser residue was phosphorylated by a proline-directed kinase
ﬁrst [18].
In mammals, there are two GSK3 isoforms (a and b). The b iso-
form (GSK3b) is the mammalian homologue to Drosophila SHAGGY.
GSK3b also plays a role in regulating the circadian clock, and many
clock proteins have been reported to be substrates of GSK3b. How-
ever, the speciﬁc effects of genetic and pharmacological interfer-
ence with GSK3b levels and activity are controversial. Inhibition
of GSK3b by lithium lengthens the circadian period in cell culture,
whereas other inhibitors such as kenpaullone shorten the period.
Downregulation of GSK3b using siRNA also causes short period
phenotypes [41]. In vivo, lithium treatment lengthens the free run-
ning period of mouse locomotor activity rhythms [55]. Interest-
ingly, although the abundance of GSK3b protein in mouse liver is
not rhythmic, its phosphorylation, which inhibits the GSK3b activ-
ity, is rhythmic [7].
Among the many proposed clock protein substrates of GSK3b is
REV-ERBa, which is stabilised upon phosphorylation by GSK3b.
Inhibition of GSK3b activity by lithium or downregulation by siRNA
lead to substantially reduced levels of the repressor REV-ERBa and
consequently to increased Bmal1 transcription [56]. The stability of
the BMAL1 protein is also regulated by GSK3b – phosphorylation
destabilises BMAL1 and targets it for proteasomal degradation
[57]. Recently, GSK3b was shown to also phosphorylate CLOCK in
a BMAL1-dependent manner. CLOCK is a direct substrate of GSK3b
and phosphorylation of CLOCK by GSK3b targets it for degradation
[58]. GSK3bwas further shown to interact with PER2 in vitro and in
vivo. In COS1 cells, phosphorylation of PER2 by GSK3b promotes
PER2 nuclear entry [59]. Yet another substrate of GSK3b is CRY2.
GSK3b was shown to phosphorylate CRY2 at serine 553, when
the protein was previously phosphorylated at serine 557. Recently,
it was shown that DYRK1A (dual-speciﬁc tyrosine-phosphorylated
and regulated kinase 1A) is responsible for this priming phosphor-
ylation of CRY2. DYRK1A kinase activity towards Ser 557 is circa-
dian with a peak of activity coinciding with the accumulation
phase of CRY2. These two subsequent phosphorylations (Ser 557
and Ser 553) target CRY2 for ubiquitination and proteasomal deg-
radation thus delaying the accumulation of CRY2 [7,60].
2.4. Adenosine monophosphate-activated protein kinase (AMPK)
Until recently little was known about kinases phosphorylating
CRY proteins in mammals. In two studies from 2007 an F-Box pro-
tein (FBXL3) was identiﬁed to bind CRY proteins and target them
for proteasomal degradation [61,62]. As F-Box proteins usually
bind to phosphorylated targets [63], there had to be at least one ki-
nase that speciﬁcally phosphorylates CRY1. CRY2 phosphorylation
by GSK3b was already described [7]. Recently, one such kinase
(AMPK) was identiﬁed. AMPK is a nutrient responsive kinase that
phosphorylates and destabilises CRY1. In mouse liver, the AMPK
activity and nuclear localisation are rhythmic and show a recipro-
cal correlation to CRY1 nuclear abundance [64].
2.5. PKA (protein kinase A)
In the Neurospora clock PKA plays an important role, both in the
positive as in the negative limb of the circadian feedback loop. By
phosphorylating FRQ, PKA stabilizes it [65], an effect opposed to
the destabilizing effect of CK1-a and CKII. In the case of WCC as a
substrate, it is a priming kinase for CK1-a and CKII. PKA activity
is essential for the circadian clock [65]. PKA was also found to be
involved in the Drosophila circadian clock [66].
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The Neurospora FRQ protein is phosphorylated by many differ-
ent kinases, among them CAMK-1. The role of CAMK-1 within
the circadian system is difﬁcult to assess as the phenotypes caused
by camk-1 deletion are only of a transient nature most likely due to
redundancy [67]. In the Drosophila circadian system, CamKII was
found to regulate CLK/CYC activity [66].
2.7. Other kinases
As described above, a variety of kinases involved in circadian
regulation has been identiﬁed. Considering the complexity of the
circadian system and the amount of multiply phosphorylated
clock components, it is reasonable to speculate that more ki-
nases are involved in ﬁne-tuning the circadian oscillator. Results
from screening experiments support this hypothesis. In a chem-
ical kinase inhibitor screen in Drosophila S2 cells, the kinases
PKA (protein kinase A), CamKII (calcium/calmodulin-dependent
kinase II) and MAPK (Ras/mitogen-activated protein kinase) were
found to regulate CLK/CYC activity [66]. In a kinase inhibitor
screen performed in oscillating mammalian cells, not only the
known kinases CKI and CK2 were identiﬁed as being involved
in circadian regulation, but also PI3-kinase and c-Jun N-terminal
kinase [68]. As this screen was performed with chemical inhibi-
tors, potential off-target effects cannot be excluded. In another
RNAi-based screen several kinases were identiﬁed as putative
clock components [49]. In a mass spectrometry approach to
identify components of the BMAL1 transcriptional activator com-
plex, protein kinase C-a (PKCa) and the receptor for activated ki-
nase C-1 (RACK1) were identiﬁed to associate with BMAL1 in a
circadian manner, and PKCa was shown to phosphorylate BMAL1
in vitro [69]. In general, understanding the speciﬁc functions of
kinases (including these newly identiﬁed) in the circadian sys-
tem will be challenging due to the fact that most kinases have
many other roles within the cell.3. Protein phosphatases
The phosphorylation of a given protein by speciﬁc kinases does
not always result in a permanent modiﬁcation that is present until
the protein is degraded. Phosphatases are enzymes that can coun-
teract the effect of kinases, thereby making phosphorylation events
potentially highly dynamic. Thus the resulting activity, stability, or
interaction properties of a protein may be regulated by the con-
certed action of kinases and phosphatases. In humans there are
approximately 500 genes coding for protein kinases. About two
thirds of these kinases phosphorylate serine and threonine resi-
dues. In contrast to this high number of protein kinases only
approximately 150 protein phosphatases are encoded, of which
less than one third are serine/threonine phosphatases. To counter-
balance this disequilibrium, one catalytic phosphatase subunit can
form complexes with many regulatory subunits (e.g., in the case of
protein phosphatase 1: one catalytic subunit with more than 50
regulatory subunits) thus giving rise to an ample variety of differ-
ent phosphatase holoenzymes [70].
Themajority of phospho-serine and phospho-threonine dephos-
phorylation in mammals is catalysed by two groups of enzymes:
phosphoprotein phosphatases (PPP) and metallo-dependent pro-
tein phosphatases (PPM). Among the PPPs are the phosphatases
that are involved in the regulation of the circadian clock (PP1,
PP2A, PP4 and PP5) [71,72]. In contrast to our knowledge about
the action of kinases on the circadian clock, we are just beginning
to understand the role of phosphatases especially in the mamma-
lian circadian clock.3.1. Protein phosphatase 1 (PP1)
The most extensive studies on the role of phosphatases in the
circadian clock were conducted in the bread mold (N. crassa). PP1
was shown to dephosphorylate FRQ in vitro. In a ppp-1 mutant
(catalytic subunit of PP1) FRQ is less stable, the phase of the circa-
dian cycle is advanced and the period shortened [73]. In Drosophila,
the overexpression of an endogenous nuclear inhibitor of PP1
(NIPP1) leads to a lengthened circadian period and reduction in
amplitude of behavioural rhythms. PP1 can dephosphorylate and
thereby stabilise TIM in cultured cells as well as pacemaker neu-
rons [74]. In the mammalian system, PER2 was shown to be a tar-
get of PP1. PER2 is stabilised by PP1-mediated dephosphorylation
and was shown to bind to PP1. Inhibition of PP1 by inhibitors or
overexpression of a dominant negative form of PP1 accelerates
PER2 degradation. In an in vitro experiment, PP1 was able to
dephosphorylate CKIe-phosphorylated PER2 [75].
3.2. Protein phosphatase 2A (PP2A)
Also protein phosphatase 2A (PP2A) is involved in the regula-
tion of the circadian clock in many organisms. In Neurospora,
PP2A was shown to dephosphorylate FRQ in vitro. In vivo, a muta-
tion in the rgb-1 gene (a regulatory PP2A subunit) does not affect
FRQ stability, but leads to decreased abundance of FRQ protein
and mRNA levels as well as long period and low amplitude oscilla-
tions [73]. Furthermore, it was shown that PP2A can dephosphor-
ylate WCC in vitro, the Neurospora transcriptional activator that is
inhibited by FRQ. FRQ rhythmically promotes the phosphorylation
and deactivation of WCC, while PP2A causes dephosphorylation
and activation of WCC [76]. This FRQ-dependent inactivation and
PP2A-dependent activation of WCC occurs in cycles in the range
of minutes and is coupled to cycles of nuclear-cytoplasmic shut-
tling [77].
In Drosophila, two regulatory subunits of PP2A, TWINS (TWS)
and WIDERBORST (WDB) are involved in regulating the circadian
clock. Both are expressed in a circadian manner and stabilise PER
in S2 cells. Inhibiting the activity of PP2A leads to long periods or
arrhythmic behaviour, while overexpression of the PP2A catalytic
subunit causes loss of rhythmic behaviour [78]. PP2A also counter-
acts the hyperphosphorylation and thereby destabilisation of CLK
by DBT [20]. Therefore the correct function of the circadian clock
in Drosophila requires a tight control of PP2A activity. It is presently
unclear, whether PP2A plays a role in the mammalian circadian
clock.
3.3. Protein phosphatase 4 and 5 (PP4 and PP5)
So far PP4 was only described to be involved in the Neurospora
circadian system. Knockout of pp4 leads to short period rhythms
with a low amplitude. PP4 regulates FRQ phosphorylation and sta-
bility and also dephosphorylates and activates WCC. It plays a ma-
jor role in promoting nuclear entry of WCC [79].
The phosphatase PP5 was described to be important in the
mammalian circadian system only. Its substrate is CKIe. PP5 acti-
vates CKIe by removing autoinhibitory phosphorylations. This ac-
tion can be inhibited by CRY2. When PP5 is downregulated in
oscillating cells, the circadian cycling is disrupted [80].
3.4. Other phosphatases
A phosphatase involved in the input pathway into the SCN is
MKP1 (MAP kinase phosphatase 1). It dephosphorylates active
phospho-MAPK and can thus shut-off the phospho-MAPK signal
transduction. Its expression proﬁle is similar to that of Per1: it is
light-induced (via CRE elements) and under the control of
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Fig. 1. Schematic representation of the main components, kinases and phospha-
tases and their interaction in the molecular circadian clock of Neurospora,
Drosophila and mammals. Transcriptional repressors in the molecular clockwork
are depicted in light blue, transcriptional activators in green. Kinases and
phosphatases are coloured according to their effect on circadian period. When
inhibition of kinase/phosphatase activity causes period lengthening, shortening or
arrhythmia, the kinase is depicted in yellow, orange or purple respectively. With no
or unclear effect on period the kinases/phosphatases are depicted in grey. Lines
between components represent interactions between kinase/phosphatase and its
substrates. (A) (Neurospora): PP1 – protein phosphatase 1, PP2A – protein
phosphatase 2A, PP4 – protein phosphatase 4, PKA – protein kinase A, CK1-a –
casein kinase I a, CAMK-1 – calcium/calmodulin-dependent protein kinase, CKII –
casein kinase 2, FRQ – frequency, WCC – white collar complex. (B) (Drosophila): PP1
– protein phosphatase 1, PP2A – protein phosphatase 2A, DBT/CKI – DOUBLETIME/
casein kinase I, CK2 – casein kinase 2, SGG/GSK-3 – SHAGGY/glykogen synthase
kinase 3, PER – PERIOD, TIM – TIMELESS, CLK – CLOCK. (C) (mammals): PP1 –
protein phosphatase 1, PP5 – protein phosphatase 5, AMPK – adenosine mono-
phosphate-activated protein kinase, CKI – casein kinase I, CK2 – casein kinase 2,
GSK-3 – glykogen synthase kinase 3, PERs – PERIOD proteins 1-3, CRYs – CRY
proteins 1 and 2, BMAL1 – brain and muscle aryl hydrocarbon receptor nuclear
translocator (ARNT)-like 1), CLOCK – circadian locomotor output cycles kaput, REV-
ERB-a – nuclear receptor subfamily 1, group D, member 1.
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tioned above do not exhaustively describe the role of phosphatases
in the circadian clock. As in the case of kinases, it is likely that more
than the phosphatases known so far are involved in the circadian
system. For example, the RNAi based screen mentioned above[49] also identiﬁed several phosphatase subunits as potential novel
clock regulators.4. Summary and outlook
Phosphorylation plays an important role in generating circa-
dian rhythms. In Fig. 1, kinases and phosphatases regulating
the phosphorylation of their clock protein substrates in Drosoph-
ila and mammals are summarised. Of course this picture can
only give a snapshot of what we think today are the main
events. New components and new interactions are very likely
to appear in the near future. But even the knowledge we have
up to now provides a very complicated and interwoven picture.
As the circadian clock network is a highly non-linear-system, the
level and activity of one component inﬂuences not only other
components but also may feed back on its own synthesis and/
or activity. In addition, kinases involved in circadian regulation
often have more than one clock protein substrate. For example,
mammalian GSK3b phosphorylates REV-ERBa and thus targets
it for degradation. Less REV-ERBa leads to higher expression
levels of BMAL1, which itself is a substrate of GSK3b and is
degraded upon phosphorylation. Thus, the resulting levels of
BMAL1 and REV-ERBa within a cell are the result of a delicate
equilibrium. To make things even more complicated, GSK3b
probably also phosphorylates other clock components, namely
PER2, CRY2 and CLOCK that also feed back onto BMAL1 synthe-
sis. An interesting aspect concerns the phosphorylation of the
positive elements of the circadian clock. In Neurospora and
Drosophila, phosphorylation of the positive factors WCC and
CLK leads to inactivation or degradation of these transcription
factors, respectively [20,76]. The phosphorylation of CLOCK and
BMAL1 targets them for degradation, but also correlates with
the times of maximal transcriptional activity [57,58]. This is in
line with models, where successful transcription of a controlled
gene is coupled to proteasomal degradation of the transcription
factor thereby restricting the activity phase of a transcription
factor [82].
For a comprehensive understanding of the impact of phosphor-
ylation on the circadian clock, knowledge on several levels has to
be accumulated. Firstly, all components need to be identiﬁed,
e.g., by pharmacological [37] or genetic screens [49,83]. Secondly,
the substrates of these kinases and phosphatases have to be iden-
tiﬁed. Thirdly, we want to know, at which circadian phase, at
which residue(s) of the substrate and to what extent a phosphopy-
lation or dephosphorylation event occurs. Finally, we need to de-
ﬁne the particular function of a speciﬁc phosphorylation or
dephosphorylation within the circadian oscillator. First efforts to-
wards these goals have been described recently for the Neurospora
repressor of circadian transcription FRQ [84]. Time-resolved phos-
phorylation patterns of the phosphorylation state of FRQ and its
quantitative change over the circadian cycle were identiﬁed. The
phosphorylation of FRQ follows a phase speciﬁc pattern for differ-
ent domains. When phosphorylation sites were mutated, the im-
pact on FRQ stability and circadian cycling varied and depended
on the combination of mutated phosphorylation sites. Such studies
providing us with a high resolution picture of dynamical phosphor-
ylation events will help us to better understand the complex ﬁne
tuning of the circadian system.
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